Graeme Bevans News Today

Atlas Arteria shareholders say IFM Investors could use its near 25 per cent stake to force a second strike at the company’s annual general meeting in May.

Chairwoman Debbie Goodin says the board takes very seriously the ‘negative sentiment’ as proxy votes against the REM report hit 35.2pc.

Atlas Arteria has fended off IFM Investors, bet the company on a US toll road, and asked its shareholders for $3 billion. It’s been a huge year but not everyone’s happy.

Atlas Arteria Limited (ASX:ALX – Get Rating) announced a final dividend on Friday, March 24th, MarketIndexAU reports. Stockholders of record on Wednesday, April 5th will be paid a dividend of 0.20 per share on Wednesday, April 5th. This represents a dividend yield of 3.08%. The ex-dividend date of this dividend is Monday, March 27th. Atlas […]

The popularity of private cars during the pandemic may have peaked as people return to buses, planes and trains.

The $200 billion global investment group is expected to drop threats to spill the tollroad group’s board once a director’s seat is secured.

Logistics giant tells AFR Infrastructure Summit “it’s still a fragile supply chain”; MPs demand inquiry into coal data falsification claims. Follow updates here.

As IFM Investors gears up to battle for more control of Atlas Arteria, it has been raising questions over the capability of the toll road company’s board and management team.

The battle between IFM and Atlas Arteria is one of a series of corporate stoushes seen this year. So what’s the reason for the argy-bargy?

FIRB approval paves the way for IFM to convert swaps to real shares.